ASX Announcements
Notification regarding unquoted securities - AVH
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities)
- Jan 9, 2025
- 8 pages
Notification regarding unquoted securities - AVH
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities)
- Jan 8, 2025
- 9 pages
This Month
Spray-on skin hopeful Avita Medical nosedives 19pc on revenue miss
The regenerative medicine company disappointed its shareholders with a revenue miss that has dragged down full-year results as hospitals slowed buying.
- Kanika Sood
December 2023
- Exclusive
- Funding
New fund targets companies battered by market doubts
Record low biotech valuations have prompted a new VC investor to start shopping with a planned $200 million fund.
- Jessica Sier
December 2022
This medtech says a $7.8b opportunity can reverse its image problem
The new CEO of spray-on skin company Avita Medical says there is a “pot of gold” on the horizon for the biotech company, but he knows investors will take some convincing.
- Updated
- Yolanda Redrup
September 2020
'Highly confident': Avita Medical says vitiligo treatment coming
Avita Medical is now valued at around $750 million as investors anticipate its Recell therapy could treat common skin disorders, as well as burns victims.
- Tom Richardson
February 2020
The value investor making a fortune where others fear to tread
The 31-year-old Michael Frazis says the market-thumping returns are going to come from companies that look expensive to investors viewing them all wrong.
- Tom Richardson
January 2020
Shares lift ahead of profit reporting season
Receding worries over the coronavirus helped send shares higher on the last trading day before February's profit reporting season.
- Tom Richardson
Healthcare outlook good for service providers, cloudy for aged care
Although forecasts vary across different parts of the sector, overall there are strong longer-term drivers.
- Carrie LaFrenz
December 2019
- Exclusive
- Healthcare
Avita tech 'revolutionising' care for burn patients, says CEO
Avita Medical has been one of the top performers this year on the ASX 200, up over 600 per cent.
- Carrie LaFrenz
November 2019
Bell Potter's skin in Avita Medical's game
Bell Potter raised $120 million this week for Avita Medical, whose 20th largest shareholder is a Bell Potter director.
- Joe Aston
Avita Medical raising $100 million
Regenerative medicine company Avita Medical is hoping to raise $100 million via an institutional placement.
- Sarah Thompson, Anthony Macdonald and Tim Boyd
November 2018
Avita Medical taps Bell Potter to raise $40m
Regenerative medicine company Avita Medical is seeking to raise up to $40 million to fund its American launch and for research and development.
- Updated
- Sarah Thompson and Anthony Macdonald
July 2014
News and returns key to biotech support
New Avita Medical chairman Lou Panaccio says the company, as well as its biotechnology sector peers, needs to better explain how and when it will deliver returns, to maintain support from investors.
- Updated
- Jessica Gardner
May 2010
Brief: Avita Medical
Avita Medical and Helicon have mutually agreed not to renew a distribution agreement for the ReCell markets in China and Taiwan.
December 2009
August 2009
Brief: Avita Medical
Avita Medical has secured regulatory approval for its ReCell Autologous Spray-On Skin from the Chinese State Food and Drug Administration (SFDA)
November 2008
CHANGE AS GOOD AS A NEW COMPANY
If you are a shareholder of Perth civil and mining contractor Brierty, changes could be in the wings. Especially if the track record of chairman WA businessman Dalton Gooding is anything to go by.
- Damon Kitney